Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Haploidentical Stem Cell Transplantation Utilizing T-Cell Depletion as Therapy for Patients With Refractory Hematological Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00145613
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:34:56.852363+00:00
Published At
2009-02-13T00:00:00+00:00
Record Updated At
2009-02-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Lymphoblastic Leukemia (ALL)", "Acute Myeloid Leukemia (AML)", "Secondary AML", "Myelodysplastic Syndrome (MDS)", "Secondary MDS", "Chronic Myeloid Leukemia", "Juvenile Myelomonocytic Leukemia (JMML)", "Paroxysmal Nocturnal Hemoglobinuria (PNH)", "Lymphoma, Non-Hodgkin", "Hodgkin Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2009-02-13"
protocolSection.identificationModule.nctId
"NCT00145613"
protocolSection.identificationModule.officialTitle
"Haploidentical Stem Cell Transplantation Utilizing T-Cell Depletion as Therapy for Patients With Refractory Hematological Malignancies"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Acute Lymphoblastic Leukemia (ALL) (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia (AML) (protocolSection.conditionsModule.conditions)
  • Secondary AML (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (MDS) (protocolSection.conditionsModule.conditions)
  • Secondary MDS (protocolSection.conditionsModule.conditions)
  • Chronic Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Juvenile Myelomonocytic Leukemia (JMML) (protocolSection.conditionsModule.conditions)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH) (protocolSection.conditionsModule.conditions)
  • Lymphoma, Non-Hodgkin (protocolSection.conditionsModule.conditions)
  • Hodgkin Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.